Mexico: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Acuerdo que determina los aditivos y coadyuvantes en alimentos, bebidas y suplementos alimenticios, su uso y disposiciones sanitarias

La Secretaría de Salud de México publicó un nuevo acuerdo que regula el uso de aditivos y coadyuvantes en alimentos, bebidas y suplementos alimenticios. El documento establece once anexos con sustancias permitidas, especifica categorías de productos y dosis máximas, y define procedimientos para solicitar el uso de aditivos no listados. ¿Cómo afectará esta regulación a la industria alimentaria y qué cambios deben implementar los fabricantes antes de su entrad

Mexico Healthcare

GT

Greenberg Traurig, LLP

Patent Law Reform In Mexico: A Strategic Turning Point, Particularly For The Pharma Sector

In April 2026, Mexico implemented a significant reform of its intellectual property legislation, with the objective to modernise the system, accelerate procedures and provide greater legal certainty to innovators.

NG

Novagraaf Group

Publicación de acciones de simplificación para trámites ante la COFEPRIS

Durante el mes agosto de 2025, la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), publicó en el Diario Oficial de la Federación (DOF) dos acuerdos relevantes que establecen medidas de simplificación administrativa para diversos trámites ante dicha autoridad.

Mexico Healthcare

GT

Greenberg Traurig, LLP

Publicación de acciones de simplificación y listados de dispositivos médicos para efectos del registro sanitario

Durante la primera quincena del mes de julio de 2025, la Comisión Federal para la Protección contra Riesgos Sanitarios ("COFEPRIS") publicó diversos acuerdos relevantes en el Diario Oficial de la Federación ("DOF")...

Mexico Healthcare

GT

Greenberg Traurig, LLP

New Agreement To Accelerate Importation Of Health Products Through PAHO.

Mexico Healthcare

O

OLIVARES

Decree For The Promotion Of Pharmaceutical Investment And The So-Called "Plant Requirement"

Mexico Healthcare

O

OLIVARES

Publicación De Acciones De Simplificación Para Trámites Ante La Comisión Federal Para La Protección De Riesgos Sanitarios

Mexico Healthcare

GT

Greenberg Traurig, LLP

Constitutional Reform Initiative Regarding Pharmaceutical Sovereignty And Safety

Mexico Healthcare

O

OLIVARES

New Mexico Becomes Third U.S. State To Prohibit PFAS In Products

Mexico Environment

BD

Beveridge & Diamond

Mexico Bans The Cultivation Of Genetically Modified Corn, Opening Door For Other Restrictions In The Future

Mexico Healthcare

BD

Beveridge & Diamond

Changes In Importation Of Health Products Coming From Abroad.

Mexico Healthcare

O

OLIVARES

An Introduction To Life Sciences

Mexico Healthcare

O

OLIVARES

Legal 500 Country Comparative Guides 2024

Mexico Healthcare

O

OLIVARES

The Supreme Court Of Justice Confirms Relevant Criteria Related To The Legal Standing To Claim The Invalidity Of A Pharmaceutical Patent

O

OLIVARES

Recent SAT Publications On Fraudulent CFDIs – Immediate Risks For Your Business

FL

Foley & Lardner

The Intriguing Intersection Of Caesar Salad And Intellectual Property

K

Klemchuk

Program To Regularize Self-Consumption Fuel Activities

EC Rubio

From Asia To Mexico: The Document Route For Your Expansion

Mexico Commercial

VT

Vazquez Tercero & Zepeda

Acuerdo para la atención de trámites de obras y trabajos de exploración, explotación o beneficio de los minerales o sustancias en áreas naturales protegidas federales

Mexico Environment

GT

Greenberg Traurig, LLP

Regulatory Certainty For Biosimilars On The Horizon

The frst time that biologics were ofcially recognised in the applicable legislation, the General Health Law, was in June 2009, with the inclusion of article 222-bis defning a ‘biologic/biotechnological product...

Mexico Healthcare

O

OLIVARES

The Patent Linkage System For Allopathic Medicines In Mexico

The decree published in the Official Gazette of the Federation on Sept. 19, 2003, added section IV of article 167 and article 167 bis of the Health Supplies Regulation were added...

O

OLIVARES

Regulatory Certainty For Biosimilars In Mexico.

The Ministry of Health and COFEPRIS released a document proposing a "Regulatory Certainty Strategy for the Pharmaceutical Sector: Biosimilars".

Mexico Healthcare

O

OLIVARES

Lo Que Hay Que Saber Sobre El Resurgimiento Del Nearshoring En México

Gracias a su proximidad a EE.UU., sus sólidas capacidades de fabricación, su fuerza laboral calificada, su rentabilidad, la resistencia de su cadena de suministro y sus acuerdos comerciales, ...

Mexico Commercial

TG

TMF Group BV

O Renascimento Do Nearshoring No México – O Que Você Precisa Saber

Mexico Commercial

TG

TMF Group BV

走近墨西哥近岸外包的复苏

Mexico Commercial

TG

TMF Group BV

Issues With The Patent Linkage System In Mexico

O

OLIVARES

Mexico's Nearshoring Resurgence – What You Need To Know

Mexico Commercial

TG

TMF Group BV

An Academic View Of Compulsory Licenses And Alternatives

O

OLIVARES

The Pharma Legal Handbook Mexico – 2022

Mexico Healthcare

O

OLIVARES

Patent Term Compensation For The Life Sciences

O

OLIVARES

Pharmaceutical Advertising 2022

Mexico Healthcare

O

OLIVARES

Mexican Authorities Remove Foodstuff Products Due To NOM 051 Labeling Requirements Non-Compliance

Mexico Consumer

FL

Foley & Lardner

Digital Health 2022

Mexico Healthcare

O

OLIVARES

Patent Term Compensation For The Life Sciences

Patent term compensation is a legal procedure whose nature and purpose is to adjust the reduction in the effective enforcement of the exclusive rights of the patented invention...

O

OLIVARES

Pharmaceutical Advertising 2022

The primary legislation for the advertising of medicinal products is the General Health Law (Ley General de Salud) (HL) and its Regulations (Reglamento de la LGS en Materia de Publicidad) (HLR).

Mexico Healthcare

O

OLIVARES

Mexican Authorities Remove Foodstuff Products Due To NOM 051 Labeling Requirements Non-Compliance

The Mexican Federal Commission for the Protection Against Sanitary Risks (Cofepris) and the Federal Consumer Prosecutor's Office (Profeco) removed more than 10,000 units of domestic...

Mexico Consumer

FL

Foley & Lardner

Digital Health 2022

Mexican legislation has not specifically defined "digital health". However, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) and other private and public entities...

Mexico Healthcare

O

OLIVARES

The Era Of Digitization: The Mexican Sanitary Agency, COFEPRIS.

Mexico Healthcare

O

OLIVARES

Pharma & Medical Device Regulation 2021

The Mexican healthcare system comprises public (social security insti¬tutions) and private sectors.

Mexico Healthcare

O

OLIVARES

Mexico Reduces The Autonomy And Independence Of The Regulatory Authority (COFEPRIS)

On August 19, 2020, "DECREE of incorporation of various administrative units and decentralized bodies of the Ministry of Health" was published in the Mexican Official Gazette

Mexico Healthcare

O

OLIVARES

Digital Health 2020

Mexican legislation has not specifically defined "digital health". However, the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) and other private and public entities are...

Mexico Healthcare

O

OLIVARES

Panorama del Emprendimiento para 2020

En los últimos años, ha aumentado la tendencia de emprender y hacer crecer un negocio propio dentro el mercado. Este tipo de iniciativas están siendo adaptadas

Mexico Technology

BC

Becerril Coca & Becerril

Mexico Issues Regulations To Approve Biologic Drugs

Mexico Healthcare

O

OLIVARES

Hacia donde vamos ...

Mexico Strategy

BC

Becerril Coca & Becerril

Modifications To The General Health Law (GHL) And The Law Of National Health Institutions (LNHI)

Mexico Healthcare

SD

Sanchez Devanny

Pharma & Medical Device Regulation 2020

Mexico Healthcare

O

OLIVARES

Healt Services Framework And Competent Authorities

Mexico Healthcare

O

OLIVARES

Regulating Cannabis Use In Mexico – Current Legal Framework

Mexico Cannabis

O

OLIVARES

ICLG Pharmaceutical Advertising 2019

Mexico Healthcare

O

OLIVARES

ICLG: Pharmaceutical Advertising 2019 – Promotional Guidelines

Mexico Healthcare

O

OLIVARES

Mexico's New Government Announces Plan To Overhaul The Health System

Mexico Healthcare

O

OLIVARES

Nanotechnologies In Mexico: Policies And Regulations

Mexico Healthcare

MI

Moeller IP Advisors

The Challenge Of Protecting Polymorphs In Mexico

BC

Becerril Coca & Becerril

Modernisation Of International Treaties – Impact On Life Sciences

O

OLIVARES

Pharmaceutical Advertising 2018

Mexico Healthcare

O

OLIVARES

IP Rights Protection And Enforcement Strategies For Plant Innovations In Mexico

Mexico Healthcare

O

OLIVARES

Life Sciences: Product Regulation And Liability In Mexico

Mexico Healthcare

O

OLIVARES

See more

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More